Established in 1962, Rockland is a global biotechnology company manufacturing leading-edge tools for basic, applied, and clinical research for academic, biopharma, diagnostic, and agbio industries. Rockland is a privately held company, operating manufacturing facilities with antibody and protein production capabilities near Philadelphia, Pennsylvania, USA.
PROMEGA
Promega designs and manufactures assays, reagents and instrumentation for cellular biology, protein analysis and genomics to advance life science discovery.
Porton Pharma Solutions
Porton Pharma Solutions, a global company with R&D, and GMP-compliant manufacturing facilities across US, EU and China, provides customer-centric innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, etc.) from pre-clinical to commercial.
Panome Bio
Panome Bio provides biomarker and mechanism discovery through Next-Generation Metabolomics, proteomics, transcriptomics, and integrated multi-omics analysis. Powered by a proprietary bioinformatics pipeline, we unlock complex biological insights, driving advancements in disease research, personalized medicine, and bioprocessing systems. Panome Bio, a leader in the biotech industry, empowers researchers and clinicians to explore the molecular intricacies of life.
OZ BIOSCIENCES
OZ Biosciences creates, develops and produces innovative molecular delivery systems specialized in transfection reagents (Magnetofection, Lipofection, Polyfection) and transduction tools (viral enhancers), mRNA (catalog and custom service), LNP: Lipid nanoparticles formulation (catalog and custom service), PNPs, adjuvants, bioproduction reagents (virus and protein production) and assay kits, for the worldwide scientific community and pharmaceutical industry. OZ Biosciences is focused on delivery technologies of biomolecules such as DNA, RNA and proteins for in vitro and in vivo applications.
NUVISAN
Your partner of choice in bringing therapeutics to life. Nuvisan is a full-service CRO and CDMO with state-of-the-art facilities in Germany and France, supporting pharmaceutical, biotech, venture capital and non-profit partners with high-quality, end-to-end solutions that accelerate the journey from early discovery to clinical development. With more than 40 years of heritage, Nuvisan has built a reputation for scientific excellence, industry expertise and seamless integration across discovery, development and manufacturing. Our centres of excellence, including drug discovery in Berlin, provide comprehensive capabilities to advance complex programs efficiently. In oncology, Nuvisan offers a comprehensive portfolio of specialised technologies and models designed to accelerate cancer therapeutic innovation. Our capabilities encompass target validation, CRISPR/RNAi screening, custom assay development, next-generation sequencing, single-cell analyses, multiplex flow cytometry, biomarker discovery and in vivo pharmacology including PK/PD and efficacy studies. With an extensive collection of cancer models and deep translational expertise, we support programs across solid tumours, hematologic malignancies, immuno-oncology and novel therapeutic modalities. By working collaboratively to adapt to each client’s unique needs, we help de-risk development and expedite the delivery of impactful oncology therapeutics to patients worldwide. | The NUVISAN group is a contract research and development and manufacturing organization (CRO/CDMO) with five sites in Germany and France as well as local experts situated in Latin America. We offer unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain to our biotech startup, pharma, non-profit, and venture capital clients – from target identification to the patient. With over 40 years of experience and a dedicated team of over 1,000 professionals, including more than 70% industry-experienced scientists and laboratory professionals, we possess the expertise to navigate the complexities of bringing innovative medicines to market. Recognizing the unique nature of each project, our teams prioritize flexible and innovative approaches and foster transparent communication to work closely with clients and effectively meet individual needs. | Your partner of choice in bringing therapeutics to life Nuvisan is a full-service contract research organisation (CRO) and development and manufacturing organisation (CDMO) with state-of-the-art laboratories in Germany and France. Our pharmaceutical, biotechnology, venture capital and non-profit clients partner with us because our high-quality end-to-end solutions and scientific expertise enable us to streamline and accelerate drug discovery and development – from ensuring target understanding to helping bring therapeutics to life. Founded over 40 years ago by a team of pharma industry innovators, Nuvisan has established a reputation for expertise and professionalism. Our team leaders have extensive experience in the biopharma industry, and our unique centres of excellence – for drug discovery in Berlin, formulation and GMP manufacturing in Sophia Antipolis, and our bioanalysis hub in Neu-Ulm – enable our experienced scientists to help guide and advance projects. We know how to discover, develop and bring the next generation of medicines to market. At the same time, we are committed to flexibility, transparency and collaboration in our approach, working closely with you to adapt to your individual needs, minimise risks and help deliver your project. Discovery: Helping you to achieve key decision milestones through deep scientific insights, innovation and collaboration. Preclinical: Enabling you to successfully develop and de-risk your preclinical candidates for a smooth transition to the clinic. CMC: Collaborating with you to advance molecules into drug products. Clinical: Providing tailored clinical solutions to fully assess your drug faster. Digital: Empowering your drug discovery and development with integrated data services, machine learning and generative AI. Research phases Supporting you with integrated, tailored solutions at every step of your drug discovery and development journey.
Novogene
Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the world. | Novogene is a global leader in Next-Generation Sequencing (NGS), Proteomics, and Metabolomics services, empowering researchers and organizations with cutting-edge multi-omics solutions. Since our founding in March 2011, we have remained at the forefront of innovation, delivering world-class services to advance discoveries in life sciences, healthcare, and beyond. With state-of-the-art laboratories and operations across the United States, the United Kingdom, Germany, China, Thailand, Korea, Singapore, and Japan, Novogene has established a strong global presence to support scientific advancements worldwide. At Novogene, we have built a highly skilled, interdisciplinary team, with the majority holding advanced degrees from top global institutions. Our high-throughput sequencing and high-performance computing platforms are designed to efficiently handle large-scale genomic data, meeting the evolving demands of life sciences and medical research with secure data storage and powerful bioinformatics analysis. Through extensive collaborations with leading academic institutions, hospitals, pharmaceutical companies, and agricultural enterprises, Novogene continues to shape the future of genomic research and precision medicine. As a trusted genomics partner, we are committed to empowering researchers worldwide with the technology, expertise, and solutions needed to advance genomics and improve life. | Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 45 NGS-related patents, as well as over 950 SCI articles with a total impact factor of more than 7970, including publications in first tiers journals such as Cell, Nature and Science. The UC Davis location of Novogene Corporation Inc. was opened in early 2016. We utilize Illumina platform to serve customers in North and South America, and we also offer PacBio and Nanopore services. Novogene Corporation Inc. is proud to have collaborated with scientists from the USA, Canada, Brazil, Colombia, Mexico, and so many more. We are excited to see this global collaboration and partnership growing. | Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 62 NGS-related patents, as well as nearly 20,000 SCI articles with a total impact factor of nearly 120,000, including publications in first-tier journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).
Norgen Biotek Corp
Norgen Biotek is a privately owned Canadian biotechnology company founded in 1998. Norgen is an ISO 9001:2015, ISO 13485:2016 certified fully-integrated Canadian biotechnology company focusing on sample collection, preservation and purification for research and diagnostic applications. Norgen’s ISO 9001, ISO 13485 certifications indicate our commitment to design, develop, manufacture and market high quality products, as well as our commitment to continually improve our company, our products and our quality management system. Norgen holds more than thirty-five issued and pending patents. Norgen has developed a unique platform technology based on a proprietary resin/matrix with many applications including the purification, concentration and clean-up of DNA, RNA, microRNA, proteins and exosomes from various specimen types. The efficient purification of these macromolecules is often the first step in diagnostics and in hundreds of molecular biological applications fueling discovery for genomics and proteomics.
NOF CORPORATION
NOF CORPORATION is the leading commercial supplier of drug delivery products such as activated PEGs, lipids and ultrapure Polysorbate 80. Our cutting edge products include Pendant type single molecule PEG linkers for ADCs and SS-lipids for nucleic acid/gene delivery and vaccines.
Nacalai USA, Inc.
Nacalai USA is located in San Diego and is a subsidiary of Nacalai Tesque, a reagent company based in Kyoto, Japan. We provide a wide range of research products in the Life Science and Analytical Chemistry fields, including various reagents, 3D cell culture vessels, IHC and protein research related products, HPLC columns, and research chemicals. Our mission is to propose and provide products that enable researchers to conduct their research with ease. If you are having trouble with your research or would like to find products new to you, please stop by our booth!